Skip to main content
. 2021 Jul 17;106(11):3184–3195. doi: 10.1210/clinem/dgab529

Figure 1.

Figure 1.

Transient conjugation. Lonapegsomatropin is a long-acting prodrug consisting of the parent drug, unmodified somatropin; an inert carrier; and a proprietary linker that temporarily binds the somatropin and carrier. The carrier has a shielding effect that minimizes renal excretion and receptor-mediated clearance. Following autocleavage of the linker under physiologic conditions, lonapegsomatropin predictably releases somatropin within therapeutic levels over one week.